Incentives and accessibility: A pilot study to promote adherence to TB prophylaxis in a high-risk community

Citation
J. Lorvick et al., Incentives and accessibility: A pilot study to promote adherence to TB prophylaxis in a high-risk community, J URBAN H, 76(4), 1999, pp. 461-467
Citations number
26
Categorie Soggetti
Envirnomentale Medicine & Public Health
Journal title
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
ISSN journal
10993460 → ACNP
Volume
76
Issue
4
Year of publication
1999
Pages
461 - 467
Database
ISI
SICI code
1099-3460(199912)76:4<461:IAAAPS>2.0.ZU;2-8
Abstract
Setting. A community-based directly observed preventive therapy (DOPT) prog ram for treatment of latent tuberculosis infection among injection drug use rs (IDUs) in an inner-city neighborhood. To test adherence to a 6-month cou rse of DOPT using cash incentives and an Objective. To test adherence to a 6-month course of DOPT using cash incenti ves and an easily accessible neighborhood location. Design. Street-recruited IDUs (N = 205) were screened for Mycobacterium tub erculosis (TB) infection using the Mantoux test and two controls. Subjects who had a purified protein derivative (PPD) reaction of greater than or equ al to 5 mm, were anergic, or had a history of a positive PPD received clini cal evaluation at a community field site, provided in collaboration with th e San Francisco Department of Public Health :Tuberculosis Clinic. Twenty-ei ght subjects were considered appropriate candidates for prophylaxis with is oniazid, and 27 enrolled in the pilot study. Participants received twice-we ekly DOPT at a community satellite office, with a $10 cash incentive at eac h visit. Results. The 6-month (26-week) regimen was completed by 24/27 (89%) partici pants. The median time to treatment completion was 27 weeks (range 26 to 34 weeks). The median proportion of dosing days attended in 6 months was 96%. Conclusion. Community-based DOPT using cash incentives resulted in high lev els ol: adherence and treatment completion among drug users.